Home › Research › Down syndrome and Alzheimer's
Down Syndrome-Basque Alzheimer Initiative (DS-BAI): Clinic-Biological Cohort
Altuna M, Estanga A, Garrido A, Saldias J, Cañada M, Echeverria M, Larrea JÁ, Ayo P et al.. Journal of clinical medicine, 2024-02-17
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Down syndrome (DS) is the most common genetically determined intellectual disability. In recent decades, it has experienced an exponential increase in life expectancy, leading to a rise in age-related diseases, including Alzheimer's disease (AD). Specific health plans for the comprehensive care of the DS community are an unmet need, which is crucial for the early and accurate diagnosis of main medical comorbidities. We present the protocol of a newly created clinical and research cohort and its feasibility in real life. Methods The Down Syndrome-Basque Alzheimer Initiative (DS-BAI) is a population-based, inclusive, multidisciplinary initiative for the clinical-assistance and clinical-biological research approach to aging in DS led by the CITA-Alzheimer Foundation (Donostia, Basque Country). It aims to achieve the following: (1) provide comprehensive care for adults with DS, (2) optimize access to rigorous and quality training for socio-family and healthcare references, and (3) create a valuable multimodal clinical-biological research platform. Results During the first year, 114 adults with DS joined the initiative, with 36% of them showing symptoms indicative of AD. Furthermore, adherence to training programs for healthcare professionals and families has been high, and the willingness to collaborate in basic and translational research has been encouraging. Conclusion Specific health plans for DS and conducting clinical and translational research on the challenges of aging, including AD, are necessary and feasible.
What this study adds
Evidence grade: Moderate
The record lists 114 participants. This paper describes a new clinical and research cohort for adults with Down syndrome, in which 114 people joined in the first year and 36% showed symptoms indicative of Alzheimer's disease. It presents a care and research platform and reports no treatment, cure or prevention results.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Altuna, M., Estanga, A., Garrido, A., Saldias, J., Cañada, M., Echeverria, M., et al. (2024). Down Syndrome-Basque Alzheimer Initiative (DS-BAI): Clinic-Biological Cohort. Journal of clinical medicine. https://doi.org/10.3390/jcm13041139
Vancouver
Altuna M, Estanga A, Garrido A, Saldias J, Cañada M, Echeverria M, et al. Down Syndrome-Basque Alzheimer Initiative (DS-BAI): Clinic-Biological Cohort. Journal of clinical medicine. 2024. doi:10.3390/jcm13041139. PMID: 38398452.
BibTeX
@article{altuna2024-38398452,
author = {Altuna, M. and Estanga, A. and Garrido, A. and Saldias, J. and Cañada, M. and Echeverria, M. and JÁ, Larrea and Ayo, P. and others},
title = {{Down Syndrome-Basque Alzheimer Initiative (DS-BAI): Clinic-Biological Cohort}},
journal = {Journal of clinical medicine},
year = {2024},
doi = {10.3390/jcm13041139},
pmid = {38398452},
url = {https://doi.org/10.3390/jcm13041139}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results During the first year, 114 adults with DS joined the initiative, with 36% of them showing symptoms indicative of AD.
Why it matters
This paper describes a new clinical and research cohort for adults with Down syndrome, in which 114 people joined in the first year and 36% showed symptoms indicative of Alzheimer's disease. It presents a care and research platform and reports no treatment, cure or prevention results.
Study details
- Participants114
- Evidence strengthModerate
How this study scored 39/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of clinical medicine) |
| Journal's citation record | 2 / 4 | Journal of Clinical Medicine: journal h-index 188 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2024 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 114 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.2 citations a year over 4 year(s) since 2024 |
| Impact for its field and year | 1 / 6 | Cited 0.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Maite García‐Sebastián: h-index 16 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Universidad de Deusto: institution h-index 183 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 38398452) |
| Free to read | 2 / 2 | Free to read |
| Total | 39 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3390/jcm13041139
- PubMed: 38398452
- Original source →
- Free full text: Journal of Clinical Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.